Whitehawk Therapeutics Inc.

NASDAQ:WHWK

1.81

+0.04 (+1.98%)

5:46:18 PM EDT: $1.78 -0.03 (-1.39%)

Whitehawk Therapeutics Inc. Stock, NASDAQ:WHWK

17383 Sunset Boulevard, Suite A250, Los Angeles, California 90272

United States of America

Phone: +1.424.473.8055

Number of Employees: 89

http://www.aadibio.com

Description

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Los Angeles, CA.